Susquehanna International Group
MHUA

Susquehanna International Group’s Meihua International Medical Technologies MHUA Stock Holding History

Susquehanna International Group’s Portfolio MHUA Stock Details MHUA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-109
Closed -$62K – 13181
2022
Q3 		$62K Buy
+109
New +$49.8K ﹤0.01% 12070

Other funds holding MHUA

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group's MHUA Position: Q4 2022 in Review

Susquehanna International Group sold out of Meihua International Medical Technologies (MHUA) in Q4 2022, closing a stake of 109 shares — an estimated $62K sold.

Susquehanna International Group first reported a position in MHUA in Q3 2022 and held it in 1 quarter. The position peaked at $62K in Q3 2022. 4 funds tracked by Wall St. Rank hold MHUA as of Q4 2022.

  • Susquehanna International Group reported no remaining Meihua International Medical Technologies position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 109 Meihua International Medical Technologies shares in Q4 2022, an estimated $62K.
  • Susquehanna International Group first reported a position in Meihua International Medical Technologies in Q3 2022 and held it in 1 quarter.
  • Susquehanna International Group's Meihua International Medical Technologies position peaked at $62K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.